课题基金 / 基金详情

EVALUATE ENTERIC-COATED CYSTEAMINE THERAPY IN PATIENTS WITH CYSTINOSIS

EVALUATE ENTERIC-COATED CYSTEAMINE THERAPY IN PATIENTS WITH CYSTINOSIS
评估肠溶半胱胺治疗胱氨酸中毒患者的疗效
批准号:
7724942
负责人:
Ranjan Dohil
金额:
$1.56万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30

项目摘要

项目成果

Ranjan Dohil的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 确定给予半胱氨酸肠溶胶囊能否降低给药频率。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine whether dose frequency can be reduced giving enteric coated cystagon capsules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EVALUATE ENTERIC-COATED CYSTEAMINE THERAPY IN PATIENTS WITH CYSTINOSIS
EVALUATE ENTERIC-COATED CYSTEAMINE THERAPY IN PATIENTS WITH CYSTINOSIS